Intraocular silicone implant to treat chronic ocular hypotony: an in vivo trial

Graefes Arch Clin Exp Ophthalmol. 2017 Oct;255(10):1947-1955. doi: 10.1007/s00417-017-3714-x. Epub 2017 Jul 3.

Abstract

Purpose: The management of chronic ocular hypotony and complicated proliferative vitreoretinopathy-related retinal detachment represents a challenge. Being non-absorbable and non-biodegradable, a silicone oil implant is expected to restore the volume and the intraocular pressure of the globe, as well as to approximate the detached retina. Further advantages could be a long-term tamponade potential, absence of toxicity, and prevention of silicone oil emulsification or anterior chamber oil-prolapse. The aim of this study was to assess the histological tolerance of the silicone oil implant in a pig model.

Methods: A seamless silicone balloon implant with optional surface modifications was developed. Mini pigs were used as experimental animals, and three variants of silicone implants with different surfaces were tested: uncoated, NCO-sP(EO-stat-PO) coated, and heparin-NCO-sP(EO-stat-PO) coated silicone implants. An extracapsular lens extraction was achieved via a standard phacoemulsification followed by a standard three-port vitrectomy. The implant was then placed in the posterior segment and filled with 5000 centistoke silicone oil. One month later, the pigs were euthanized, the eyes were enucleated, and histological specimens were prepared for microscopy.

Results: The analysis of the histology revealed that adverse histological changes in conjunctiva, cornea, iris, and ciliary body could be excluded in all eyes operated on regardless of which variant of implant had been employed. The retina as the implant-contacting ocular tissue showed overall good tolerance, although some inflammatory reaction and fibrous proliferation was evident in some cases.

Conclusions: The silicone oil implant is a promising candidate and has the potential to fulfill clinical requirements to act as a long-term intraocular tamponade agent. The heparin-NCO-sP(EO-stat-PO) coating approach could lead to a novel bioactive surface for intraocular devices with excellent properties to hinder cell adhesion and protein adsorption, although further studies will be necessary to evaluate long-term biocompatibility and long-term resistance to biological attacks.

Keywords: Histological tolerance; Ocular hypotony; Proliferative vitreoretinopathy; Silicone oil implant.

MeSH terms

  • Animals
  • Chronic Disease
  • Disease Models, Animal
  • Follow-Up Studies
  • Intraocular Pressure / physiology*
  • Ocular Hypotension / pathology
  • Ocular Hypotension / physiopathology
  • Ocular Hypotension / surgery*
  • Prostheses and Implants*
  • Prosthesis Design
  • Retina / pathology*
  • Silicone Elastomers / administration & dosage*
  • Swine
  • Swine, Miniature

Substances

  • Silicone Elastomers